Department of Radiation Oncology 350 W. Thomas Road Phoenix, AZ USA
Phone
:
602-406-3170
Fax
:
602-263-7816
E-mail
:
null
Website
:
www.arizonaoncology.com
Treatment
:
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303